Evidence map›Paper›PMID 20418371›Full record

ArticleThe Journal of biological chemistry2010

Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways.

Jing Pan, Yi Qian, Xiaodong Zhou, Hong Lu, Eduardo Ramacciotti, Lijuan Zhang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Galactosaminoglycans: Medical Applications and Drawbacks.Molecules (Basel, Switzerland) · 2019
    Review
  10. Article
  11. Review
  12. Heparin Mimetics: Their Therapeutic Potential.Pharmaceuticals (Basel, Switzerland) · 2017
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Glycosaminoglycans in biomedicine.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jing PanDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. ljzhang@wustl.edu
Yi Qian
Xiaodong Zhou
Hong Lu
Eduardo Ramacciotti
Lijuan Zhang
Washington University in St. Louis · USLoyola University Medical Center · US

Funding

Glycosaminoglycans in FGF/FGFR Signaling.R01GM069968 · NIGMS · WASHINGTON UNIVERSITY · PI ZHANG, LIJUAN · 2004 to 2008
$1.5M
NIGMS NIH HHS R01 GM069968NIGMS NIH HHS R01GM069968
6 · The paper itself

Abstract

Contaminated heparin was associated with adverse reactions by activating the contact system. Chemically oversulfated/modified glycosaminoglycans (GAGs) consisting of heparan sulfate, dermatan sulfate, and chondroitin sulfate have been identified as heparin contaminants. Current studies demonstrated that each component of oversulfated GAGs was comparable with oversulfated chondroitin sulfate in activating the contact system. By testing a series of unrelated negatively charged compounds, we found that the contact system recognized negative charges rather than specific chemical structures. We further tested how oversulfated GAGs and contaminated heparins affect different cell signaling pathways. Our data showed that chemically oversulfated GAGs and contaminated heparin had higher activity than the parent compounds and authentic heparin, indicative of sulfation-dominant and GAG sequence-dependent activities in BaF cell-based models of fibroblast growth factor/fibroblast growth factor receptor, glial cell line-derived neurotrophic factor/c-Ret, and hepatocyte growth factor/c-Met signaling. In summary, these data indicate that contaminated heparins intended for blood anticoagulation not only activated the contact system but also modified different GAG-dependent cell signaling pathways.

Indexed as

AnimalsCell LineCell ProliferationDermatan SulfateGlycosaminoglycansHeparan SulfateHeparinHumansIntercellular Signaling Peptides and ProteinsKallikreinsReceptors, Growth FactorSignal TransductionThrombinDermatan SulfateGlycosaminoglycansHeparan SulfateHeparinIntercellular Signaling Peptides and ProteinsKallikreinsReceptors, Growth FactorThrombin

Identifiers

PMID20418371
PMCPMC2906290
OpenAlexW2075829402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.